Literature DB >> 34713304

GRP78 facilitates M2 macrophage polarization and tumour progression.

Heng Zhang1,2,3, Shao-Qiang Wang4, Lin Hang1, Chun-Fang Zhang1,2,3, Li Wang5,6, Chao-Jun Duan1,3, Yuan-Da Cheng1,2,3, Dong-Kai Wu7, Ri Chen8.   

Abstract

This study investigated the regulation of GRP78 in tumour-associated macrophage polarization in lung cancer. First, our results showed that GRP78 was upregulated in macrophages during M2 polarization and in a conditioned medium derived from lung cancer cells. Next, we found that knocking down GRP78 in macrophages promoted M1 differentiation and suppressed M2 polarization via the Janus kinase/signal transducer and activator of transcription signalling. Moreover, conditioned medium from GRP78- or insulin-like growth factor 1-knockdown macrophages attenuated the survival, proliferation, and migration of lung cancer cells, while conditioned medium from GRP78-overexpressing macrophages had the opposite effects. Additionally, GRP78 knockdown reduced both the secretion of insulin-like growth factor 1 and the phosphorylation of the insulin-like growth factor 1 receptor. Interestingly, insulin-like growth factor 1 neutralization downregulated GRP78 and suppressed GRP78 overexpression-induced M2 polarization. Mechanistically, insulin-like growth factor 1 treatment induced the translocation of GRP78 to the plasma membrane and promoted its association with the insulin-like growth factor 1 receptor. Finally, IGF-1 blockade and knockdown as well as GRP78 knockdown in macrophages inhibited M2 macrophage-induced survival, proliferation, and migration of lung cancer cells both in vitro and in vivo.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  JAK1/2; NSCLC; STAT3/6; TAM

Mesh:

Substances:

Year:  2021        PMID: 34713304     DOI: 10.1007/s00018-021-03997-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  53 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.

Authors:  Steven L Wood; Maria Pernemalm; Philip A Crosbie; Anthony D Whetton
Journal:  Cancer Treat Rev       Date:  2013-10-15       Impact factor: 12.111

Review 3.  The tumor microenvironment in non-small-cell lung cancer.

Authors:  Edward E Graves; Amit Maity; Quynh-Thu Le
Journal:  Semin Radiat Oncol       Date:  2010-07       Impact factor: 5.934

4.  Clinical significance of the tumor microenvironment in non-small cell lung cancer.

Authors:  Katsuhiko Shimizu; Riki Okita; Masao Nakata
Journal:  Ann Transl Med       Date:  2013-07

Review 5.  Non-small-cell lung cancer.

Authors:  Cesare Gridelli; Antonio Rossi; David P Carbone; Juliana Guarize; Niki Karachaliou; Tony Mok; Francesco Petrella; Lorenzo Spaggiari; Rafael Rosell
Journal:  Nat Rev Dis Primers       Date:  2015-05-21       Impact factor: 52.329

Review 6.  The Microenvironment of Lung Cancer and Therapeutic Implications.

Authors:  Vivek Mittal; Tina El Rayes; Navneet Narula; Timothy E McGraw; Nasser K Altorki; Mary Helen Barcellos-Hoff
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 7.  Tumor-associated macrophages: from mechanisms to therapy.

Authors:  Roy Noy; Jeffrey W Pollard
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

Review 8.  Tumor-associated macrophages: from basic research to clinical application.

Authors:  Li Yang; Yi Zhang
Journal:  J Hematol Oncol       Date:  2017-02-28       Impact factor: 17.388

9.  Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.

Authors:  Benjamin Y Owusu; Shantasia Thomas; Phanindra Venukadasula; Zhenfu Han; James W Janetka; Robert A Galemmo; Lidija Klampfer
Journal:  Oncotarget       Date:  2017-05-29

10.  Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.

Authors:  Shui-Qing Wu; Ran Xu; Xue-Feng Li; Xiao-Kun Zhao; Bin-Zhi Qian
Journal:  Oncotarget       Date:  2018-05-18
View more
  3 in total

Review 1.  Research Progress of DUB Enzyme in Hepatocellular Carcinoma.

Authors:  Jie Zhao; Jinhui Guo; Yanan Wang; Qiancheng Ma; Yu Shi; Feng Cheng; Qiliang Lu; Wen Fu; Guangxiong Ouyang; Ji Zhang; Qiuran Xu; Xiaoge Hu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

2.  ER Stress-Related Genes EIF2AK3, HSPA5, and DDIT3 Polymorphisms are Associated With Risk of Lung Cancer.

Authors:  Yongshi Liu; Xiaohua Liang; Hongpei Zhang; Jiajia Dong; Yan Zhang; Juan Wang; Chunmei Li; Xiangbing Xin; Yan Li
Journal:  Front Genet       Date:  2022-07-14       Impact factor: 4.772

Review 3.  Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential.

Authors:  Armel H Nwabo Kamdje; Paul F Seke Etet; Maulilio J Kipanyula; Lorella Vecchio; Richard Tagne Simo; Alfred K Njamnshi; Kiven E Lukong; Patrice N Mimche
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.